SCHEMBL362572

SCHEMBL362572

Cn1c(OC2CN(C(C)(C)C)C2)nc2c(N3CCOCC3)nc(Cl)nc21

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 7/20 0.42
HDAC1 Q13547 1/20 0.39
TNF P01375 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
NT5E P21589 1/20 0.35
CYP3A4 P08684 1/20 0.34
PIK3CA P42336 4/20 0.34
HRH3 Q9Y5N1 2/20 0.33
CNR2 P34972 1/20 0.32
PDE10A Q9Y233 1/20 0.31
PIK3CG P48736 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18032516 0.86 TNF (0.42) PIK3CDHDAC1TNFSMN1; SMN2NT5E
SCHEMBL18032512 0.84 HDAC1 (0.42) PIK3CDHDAC1TNFSMN1; SMN2NT5E
SCHEMBL358553 0.84 PIK3CD (0.46) PIK3CDHDAC1TNFSMN1; SMN2PIK3CA
SCHEMBL18032511 0.83 PIK3CD (0.52) PIK3CDHDAC1TNFSMN1; SMN2NT5E
SCHEMBL18032506 0.83 TNF (0.41) PIK3CDHDAC1TNFSMN1; SMN2NT5E
SCHEMBL357452 0.82 PIK3CD (0.61) PIK3CDHDAC1TNFSMN1; SMN2NT5E
SCHEMBL358089 0.81 TNF (0.48) PIK3CDHDAC1TNFSMN1; SMN2PIK3CA
SCHEMBL18032514 0.80 HRH3 (0.46) PIK3CDHDAC1TNFSMN1; SMN2NT5E
SCHEMBL18032509 0.80 TNF (0.55) PIK3CDHDAC1TNFSMN1; SMN2NT5E
SCHEMBL362463 0.80 PIK3CD (0.44) PIK3CDHDAC1TNFSMN1; SMN2NT5E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593455-A1 PURINE COMPOUNDS SELECTIVE FOR I3 P110 DELTA, AND METHODS OF USE F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007493-A1 PURINE COMPOUNDS SELECTIVE FOR ΡI3Κ P110 DELTA, AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed